DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

103.75 6.40 (6.57%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRTX $103.75 6.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.12
Previous Close $97.35
Daily Range $97.54 - $105.53
52-Week Range $58.06 - $105.53
Market Cap $24.7B
P/E Ratio -48.92
Dividend (Yield) $0.00 (0.0%)
Volume 6,285,339
Average Daily Volume 1,148,881
Current FY EPS -$2.81





Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website:

News & Commentary Rss Feed

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Midday Gainers From September 19 - Alibaba Group Holding Ltd, Concur Technologies, Inc. And More

Nasdaq 100 Movers: MU, AMZN

Nasdaq 100 Movers: VRTX, YHOO

Uncertainty Prevails For Vertex

3 Stocks Underperforming Today In The Health Care Sector

Benzinga's Top Upgrades

Goldman Sachs Upgrades Vertex Pharmaceuticals To Buy

Commit To Buy Vertex Pharmaceuticals At $60, Earn 6.7% Using Options

S&P 500 Movers: KORS, VRTX

Vertex Pharmaceuticals (VRTX) Is Today's Strong On High Volume Stock

See More VRTX News...

VRTX's Top Competitors

VRTX $103.75 (6.57%)
Current stock: VRTX
AMGN $144.01 (1.40%)
Current stock: AMGN
GILD $105.96 (0.03%)
Current stock: GILD
BIIB $329.24 (-0.23%)
Current stock: BIIB